Terns Pharmaceuticals, Inc.

NasdaqGS:TERN Stock Report

Market Cap: US$4.5b

Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TERN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Oct 25SellUS$7,407Emil KuriakoseIndividual944US$7.85
01 Jul 25SellUS$3,640Emil KuriakoseIndividual853US$4.27
27 Jun 25BuyUS$39,283Andrew GengosIndividual10,000US$3.93
25 Jun 25BuyUS$90,230Amy BurroughsIndividual23,314US$3.87
16 Jun 25BuyUS$57,083Andrew GengosIndividual15,000US$3.95
01 Apr 25SellUS$2,366Emil KuriakoseIndividual952US$2.49
02 Jan 25SellUS$25,607Emil KuriakoseIndividual4,481US$5.71
02 Jan 25SellUS$35,702Jill QuigleyIndividual6,240US$5.72
02 Jan 25SellUS$46,524Mark VignolaIndividual8,129US$5.72

Insider Trading Volume

Insider Buying: TERN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TERN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders233,0450.214%
Hedge Funds13,827,10012.7%
VC/PE Firms14,390,74613.2%
General Public22,751,21720.9%
Institutions57,565,17352.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.1%.

Top Shareholders

Top 25 shareholders own 69.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.47%
Soleus Capital Management, L.P.
8,127,100US$337.4m-0.49%11.83%
6.94%
Morgan Stanley
7,543,167US$313.2m4.65%0.03%
6.89%
Deep Track Capital, LP
7,495,000US$311.2m0%5.5%
6.34%
Vivo Capital, LLC
6,895,746US$286.3m0%13.75%
5.24%
Commodore Capital LP
5,700,000US$236.7m0%8.07%
5.1%
BlackRock, Inc.
5,551,308US$230.5m1.48%no data
4.19%
The Vanguard Group, Inc.
4,559,917US$189.3m5.89%no data
4.03%
OrbiMed Advisors LLC
4,386,778US$182.1m-42%2.45%
3.62%
Adage Capital Management, L.P.
3,939,000US$163.5m208%0.25%
2.18%
Candriam, Société En Commandite Par Actions
2,368,235US$98.3m0%0.25%
1.81%
Acorn Bioventures
1,971,264US$81.8m0%28.2%
1.74%
Schonfeld Strategic Advisors LLC
1,891,925US$78.6m-38%0.55%
1.58%
Geode Capital Management, LLC
1,714,552US$71.2m4.97%no data
1.48%
State Street Global Advisors, Inc.
1,605,693US$66.7m16.9%no data
1.46%
Citadel Advisors LLC
1,589,334US$66.0m-59.2%0.05%
1.35%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,469,371US$61.0m24.9%0.01%
1.34%
Dimensional Fund Advisors LP
1,456,401US$60.5m-11.8%0.01%
1.17%
Franklin Resources, Inc.
1,277,396US$53.0m0%0.02%
1.02%
Pictet Asset Management Limited
1,104,204US$45.8m0%0.03%
0.89%
UBS Asset Management AG
972,772US$40.4m-17%no data
0.87%
Integral Health Asset Management, LLC
950,000US$39.4m35.7%2.47%
0.87%
Millennium Management LLC
941,584US$39.1m-5.54%0.03%
0.86%
Parkman Healthcare Partners LLC
934,760US$38.8m14.3%3.73%
0.73%
Superstring Capital Management LP
789,646US$32.8m-38.6%21.16%
0.65%
Bank of America Corporation
704,771US$29.3m42.7%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/29 20:01
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Terns Pharmaceuticals, Inc. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBarclays
Etzer DaroutBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research